BURR RIDGE, Ill., Oct. 25, 2023 /PRNewswire/ -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced nonsurgical treatment for common skin cancer, today announced its availability in Delaware at an event at Cape Henlopen Dermatology in Lewes. This is the first medical practice in the state to offer the GentleCure treatment experience.
Image-Guided SRT is the only treatment for nonmelanoma skin cancer (basal and squamous cell carcinoma) that uses ultrasound imaging to help clinicians direct low-level x-rays to targeted areas of the skin, killing cancer cells without bleeding, pain, surgical scarring or need for reconstructive surgery. A study published in the journal Oncology and Therapy showed that Image-Guided SRT produces a 99.3 percent cure rate for early stage nonmelanoma, making it just as effective as traditional surgical treatment.
Kathryn O'Reilly, M.D., Ph.D., of Cape Henlopen Dermatology, noted, "Some 8,500 Delawareans are expected to be diagnosed with nonmelanoma skin cancer this year alone. It is essential for them to have information on all available treatment options, both surgical and nonsurgical, so they can make informed decisions about their care. Image-Guided SRT is one of the most exciting technological innovations in dermatology today. We call it the GentleCure experience, and we are proud to be the first in Delaware to offer it."
Practice co-owner Mitchell Stickler, M.D., added, "For individuals who are fearful of surgery and for those whose other medical conditions make them poor candidates for Mohs surgery, noninvasive Image-Guided SRT is a much-needed option.As we diagnose over 150 nonmelanoma skin cancers per month here at Cape Henlopen Dermatology, Image-Guided SRT is a very welcome tool to add to our armamentarium against the local skin cancer epidemic. We are pleased to be the first practice to offer this technology in the First State."
Also speaking at the event was Lewes City Councilman Khalil Saliba, who said, "This is a very exciting development for the Town of Lewes and our surrounding communities, and I congratulate Drs. O'Reilly and Stickler for their vision and diligence in introducing this cutting-edge treatment to the state of Delaware. Skin cancer is a constant concern in active communities like Lewes. Our bike trails, beaches, and other outdoor activities increase the risks of sun exposure, so this new treatment is welcome, particularly since Delaware residents will no longer need to travel to other states to access this advanced technology."
"We at SkinCure Oncology are delighted to partner with Cape Henlopen Dermatology to offer this highly effective, noninvasive treatment option for their patients," said Kerwin Brandt, Chief Executive Officer of the Chicago-based company. "Patients everywhere should have the choice of curing their nonmelanoma skin cancer without surgery."
About SkinCure OncologySkinCure Oncology is the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most advanced nonsurgical treatment for common skin cancer. The company partners with quality-focused dermatologists, Mohs surgeons and other physicians to bring cancer center-level radiation therapy treatment to private practices. Presented to patients as the GentleCure experience, Image-Guided SRT is available from some 500 physicians nationwide, with more than 65,000 patients having been treated. Learn more about the company atSkinCureOncology.com, and visitGentleCure.comfor helpful consumer and patient information.
Media Contact:Matt Russell Russell Public Communications 520-232-9840 [emailprotected]
SOURCE SkinCure Oncology
Originally posted here:
Cape Henlopen Dermatology Is First in Delaware to Offer ... - PR Newswire
- Is AI Coming for My Job?: Familiarizing Clinicians with AI Tools and Their Role in Dermatology - Dermatology Times - November 12th, 2024 [November 12th, 2024]
- Almiralls Nine-Month 2024 Results: Almirall Reports Strong Performance at Q3 2024 - Driven by Successful Commercial Execution of the Dermatology... - November 12th, 2024 [November 12th, 2024]
- Updates on the Latest Cosmetic Treatments in Medical Care - Dermatology Times - November 12th, 2024 [November 12th, 2024]
- Jenny Murase, MD: Emerging Therapies Bring Hope to Patients with Persistent Itch - Dermatology Times - November 12th, 2024 [November 12th, 2024]
- POLL: Are You Attending the Elevate-Derm West Conference? - Dermatology Times - November 12th, 2024 [November 12th, 2024]
- Memorial Health System is re-opening of Department of Dermatology - Parkersburg News - October 26th, 2024 [October 26th, 2024]
- Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis - Dermatology Times - October 26th, 2024 [October 26th, 2024]
- Sun Pharma Announces Multiple Data Presentations Highlighting its Dermatology Portfolio to be Featured at the 2024 Fall Clinical Dermatology... - October 26th, 2024 [October 26th, 2024]
- What To Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD - MD Magazine - October 26th, 2024 [October 26th, 2024]
- Navigating Complexities and Unmet Needs of Chronic Hand Eczema - Dermatology Times - October 26th, 2024 [October 26th, 2024]
- Schweiger Dermatology Group Expands in Florida with the Acquisition of ClearlyDerm, Adding 5 New Offices in South Florida - PR Newswire - October 26th, 2024 [October 26th, 2024]
- Leo Pharma tells doctors to 'Talk to the Hand' in new dermatology campaign - FiercePharma - October 26th, 2024 [October 26th, 2024]
- Dermatology Partners To Expand Maryland Presence With New Westminster Clinic, Hosts Free Skin Cancer Screenings For Veterans On November 11 - citybiz - October 26th, 2024 [October 26th, 2024]
- Peter Lio, MD: The Latest Perspectives on Pathophysiology and Treatment of Eczema - Dermatology Times - October 26th, 2024 [October 26th, 2024]
- Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell... - October 26th, 2024 [October 26th, 2024]
- Dermatology Patients Taking Biologics are Wary About Most Vaccines - Medpage Today - October 13th, 2024 [October 13th, 2024]
- Safe and Effective: Upadacitinib Shows Promise in PN Treatment - Dermatology Times - October 13th, 2024 [October 13th, 2024]
- SPONSORED: First Care, Heartland Dermatology team up again for free health screening event - Hays Post - October 13th, 2024 [October 13th, 2024]
- Global Dermatology Drugs Market to Worth Over US$ 50.42 Billion By 2032 | Astute Analytica - GlobeNewswire - October 13th, 2024 [October 13th, 2024]
- Working to Improve Mental Health - Dermatology Times - October 13th, 2024 [October 13th, 2024]
- Bimekizumab Demonstrates Safety and Efficacy in Elderly Patients with Psoriasis - Dermatology Times - October 13th, 2024 [October 13th, 2024]
- Analyzing Efficacy and Safety in Diverse Clinical Trials: New Roflumilast Data - Dermatology Times - October 2nd, 2024 [October 2nd, 2024]
- UCB at EADV 2024: committed to advancing care in immuno-dermatology - UCB - October 2nd, 2024 [October 2nd, 2024]
- Positive Results Reported in Roflumilast 0.15% for AD Across Diverse Populations - Dermatology Times - October 2nd, 2024 [October 2nd, 2024]
- Expert Insights Into Handling Treatment Challenges and Site-Specific Concerns in Vitiligo Management - Dermatology Times - October 2nd, 2024 [October 2nd, 2024]
- Dermatology Excimer Laser Market is expected to Double Its Size - openPR - October 2nd, 2024 [October 2nd, 2024]
- InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and... - October 2nd, 2024 [October 2nd, 2024]
- Discussing Unmet Needs Among Patients in Dermatology, with Matthew Zirwas, MD - MD Magazine - September 23rd, 2024 [September 23rd, 2024]
- Organon Moves Into Branded Dermatology With Dermavant Takeout - Scrip - September 23rd, 2024 [September 23rd, 2024]
- Dermatology Research Team Investigating the Most Common Disease Youve Never Heard About - University of Miami - September 23rd, 2024 [September 23rd, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress - Business Wire - September 23rd, 2024 [September 23rd, 2024]
- Hensin Tsao, MD, PhD: TIL Therapy and Neoadjuvant Treatment for Pigmented Lesions - Dermatology Times - September 23rd, 2024 [September 23rd, 2024]
- Derm In The News: September 8-14 - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- Nearly half of FDA-authorized AI tools may be ineffective - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- Dermatology Diagnostic Devices And Therapeutics Market - openPR - September 15th, 2024 [September 15th, 2024]
- Industry Deep Dive: Dermatology Devices Market Size, Share, and Growth Forecast with Emerging Trends through 2032 - openPR - September 15th, 2024 [September 15th, 2024]
- SPROUT Trial Highlights Benefits of Apremilast for Pediatric Psoriasis - Dermatology Times - September 15th, 2024 [September 15th, 2024]
- Veterinary Dermatology Drugs Market Global Latest Trends and Insights 2024 to 2031 - openPR - September 15th, 2024 [September 15th, 2024]
- Championing equity in skin of color dermatology - Fierce healthcare - August 5th, 2024 [August 5th, 2024]
- Derm In The News: July 28-August 3 - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Interview Intersection: Expert Interviews From July 2024 - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Generation Z, Millennials Exhibit Similar Subjective Perception of Atopic Dermatitis Disease Severity - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Long-Term Efficacy and Insights from POETYK PSO-1 Studies: Implications for Psoriasis Treatment - Dermatology Times - August 5th, 2024 [August 5th, 2024]
- Laurel Dermatology emphasizes the importance of sunscreen - WDAM - July 26th, 2024 [July 26th, 2024]
- The Interplay Between Sleep Disorders and Dermatology - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Latex Gloves and the Americans With Disabilities Act - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Advanced Practice Providers Share Insights at the 2024 Society for Pediatric Dermatology Annual Meeting - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Almiralls H1 2024 Results: Almirall Delivers Strong Performance in the First Half of 2024, Achieving Net Sales Growth of 6.7% Driven by Its European... - July 26th, 2024 [July 26th, 2024]
- Arcutis Submits sNDA for Roflumilast Foam to FDA for Scalp and Body Psoriasis - Dermatology Times - July 26th, 2024 [July 26th, 2024]
- Appier and SkinX Thailand Partner to Revolutionise Dermatology Services with AI - SME Magazine - July 26th, 2024 [July 26th, 2024]
- Diagnostic dermatology market to be valued at $43.4b by 2034 - Healthcare Asia - July 26th, 2024 [July 26th, 2024]
- FDNY Partners with American Academy of Dermatology to Provide Free Skin Cancer Checks - nyc.gov - June 1st, 2024 [June 1st, 2024]
- Day 1 Recap: 2024 Fall Clinical Dermatology Conference for PAs and NPs - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- Dermatology's Rosanne Paul discusses safety of foot peels - The Daily | Case Western Reserve University - June 1st, 2024 [June 1st, 2024]
- Sneak Peek: 2024 Fall Clinical Dermatology Conference for PAs and NPs - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- New Dermatology Center to Open at The Grand Resort's Med Spa - businessjournaldaily.com - June 1st, 2024 [June 1st, 2024]
- Dermatology Care of Alabama goes the extra mile to give the best care - Hoover Sun - June 1st, 2024 [June 1st, 2024]
- QUIZ RECAP: Treatment and Management of Skin Cancer - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- What to Know About Peptides, the Retinol Alternative Dermatologists Love | SELF - Self - June 1st, 2024 [June 1st, 2024]
- Reviewing Common and Prevalent Dermatoses in AAPI Patients - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- Dermatologists Advise Against Taking Bite Of Facial Cream - The Onion - June 1st, 2024 [June 1st, 2024]
- Prescription Dermatology Therapeutics Market Drivers And Restraints Identified Through SWOT Analysis 2030 - openPR - June 1st, 2024 [June 1st, 2024]
- Derm In The News: May 19-25 - Dermatology Times - June 1st, 2024 [June 1st, 2024]
- What Gen Z Should Know About Sunscreen to Help Protect From Skin Cancer - The New York Times - June 1st, 2024 [June 1st, 2024]
- American Academy of Dermatology Association Statement on Reports on Counterfeit Injectables - Newswise - April 15th, 2024 [April 15th, 2024]
- Surface Area of IL-23's Epitope Influences Short- and Long-Term Responses for IL-23 Inhibitors in Plaque Psoriasis - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Atopic Dermatitis (Eczema): 5 Top Self-Care Tips - Everyday Health - April 15th, 2024 [April 15th, 2024]
- Derm In The News: April 7-13 - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Generative models improve fairness of medical classifiers under distribution shifts - Nature.com - April 15th, 2024 [April 15th, 2024]
- A 30-Year-Old White Female Presented With a 4-Month History of Scaly, Erythematous Patches and Plaques on Her ... - MDedge - April 15th, 2024 [April 15th, 2024]
- 9 Best Baby Eczema Creams of 2024 to Soothe Delicate Skin, According to Dermatologists - Allure - April 15th, 2024 [April 15th, 2024]
- QUIZ: Test Your Knowledge of Rosacea Etiology, Types, and Triggers - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Empowering Patients: Effective Dermatologic Treatment Selection for Hand and Feet AD - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- How To Treat Strawberry Legs, According To Dermatologists - Women's Health - April 15th, 2024 [April 15th, 2024]
- Rosacea Awareness Month: Resources to Share With Your Patients - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Understanding Drug Interactions in Systemic Treatment: Impact on Atopic Dermatitis Symptoms - Dermatology Times - April 15th, 2024 [April 15th, 2024]
- Derm In The News: March 31-April 6 - Dermatology Times - April 7th, 2024 [April 7th, 2024]
- Dr. Hillary Johnson-Jahangir of Forefront Dermatology Designated as a Candela Center of Excellence - PR Newswire - April 7th, 2024 [April 7th, 2024]
- How to Boost Your Immune System While Living With Psoriasis - Everyday Health - April 7th, 2024 [April 7th, 2024]